Skip to main content

Advertisement

Log in

Development and Validation of a Method for Assay of the Original Antituberculosis Agent Thiozonide in Plasma for Pharmacokinetic Studies

  • STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS AND PROCESS CONTROL
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

A method for assaying the antituberculosis drug thiozonide in plasma was developed and validated. Sample preparation consisted of precipitation of proteins with acetonitrile. Assay was by HPLC with a mass-selective detector. The method developed here was validated in terms of the following validation properties: selectivity, linearity, accuracy, precision, quantitative detection limit, sample transfer, and solution stability. The analytical range of the method was 1 – 1000 ng/ml thiozonide in plasma. This analytical range allows this method to be used for further studies of the pharmacokinetics of the innovative drug thiozonide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig 4
Fig. 5

Similar content being viewed by others

References

  1. Decree “Approval of a Strategy for the Development of the Pharmaceutical Industry to 2020” [in Russian], Ministry of Industry and Trade, Moscow (2009); URL: http://www.minpromtorg.gov.ru/ministry/strategic/sectoral/7/utverzhdennayastrategiyafarma2020231009.pdf.

  2. M. I. Perel’man, Phthysiatry. National Guidelines [in Russian], GEOTAR, Moscow (2007), pp. 10 – 22.

  3. A. G. Khomenko, Handbook of Internal Diseases. Tuberculosis [in Russian], Meditsina, Moscow (1996), pp. 7 – 10.

  4. Global Tuberculosis Report 2013 [in Russian], URL: http://www.who.int/tb/publications/globalreport/ru/.

  5. G. R. Davies and E. L. Nuermberger, Tuberculosis, Supplement 1, 65 – 74 (2008).

    Google Scholar 

  6. L. S. Strachunskii, Yu. B. Belousov, and S. N. Kozlov (eds.), Practical Guidelines for Antiinfection Treatment [in Russian], NIIAKh SGMA, Smolensk (2007), pp. 286 – 290.

    Google Scholar 

  7. D. J. Guzman, X. Montes-Rincon andW. Ribon, “Research and Development of New Drugs Against Tuberculosis”, in: Tuberculosis = Current Issues in Diagnosis and Management, inTech, Bogota, Bucaramanga, Colombia (2013), Chapter 16.

  8. G. D. Kapanadze, Author’s Abstract of Doctoral Thesis in Biological Sciences, Moscow (2011).

    Google Scholar 

  9. A. N. Mironov (ed.), Guidelines for Expert Evaluation of Drugs [in Russian], T. I, Grif i K, Moscow (2013).

  10. Guidance for Industry: Bioanalytical Method Validation, U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evolution and Research (CDER), U. S. Government Printing Office, Washington, DC (2001).

  11. Guideline on Validation of Bioanalytical Methods (draft), European Medicines Agency, Committee for Medicinal Products for Human Use, London (2009).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. V. Ramenskaya.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 49, No. 3, pp. 46 – 10, March, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramenskaya, G.V., Shokhin, I.E., Men’shikova, L.A. et al. Development and Validation of a Method for Assay of the Original Antituberculosis Agent Thiozonide in Plasma for Pharmacokinetic Studies. Pharm Chem J 49, 199–202 (2015). https://doi.org/10.1007/s11094-015-1254-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-015-1254-4

Keywords

Navigation